An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer

NCT01664494 · clinicaltrials.gov ↗

COMPLETED

Status

563

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer, Colorectal Cancer, Gastric Cancer

Interventions

DRUG: Capecitabine

Sponsor

Hoffmann-La Roche